91061-51-7 Usage
Description
(2,4-dimethylphenyl)(hydroxy)acetic acid, also known as 2,4-dimethylphenyl hydroxyacetic acid, is a carboxylic acid with the chemical formula C10H12O3. It features a hydroxy group and a phenyl ring with two methyl substituents, making it a versatile compound for various applications.
Uses
Used in Pharmaceutical Industry:
(2,4-dimethylphenyl)(hydroxy)acetic acid is used as a building block for the synthesis of pharmaceuticals due to its unique structure and reactivity. It can be incorporated into the development of new drugs and medicines, contributing to the advancement of healthcare.
Used in Organic Synthesis:
(2,4-dimethylphenyl)(hydroxy)acetic acid is used as an intermediate in organic synthesis for the creation of various organic compounds. Its properties allow it to be a key component in the synthesis of complex organic molecules, expanding the scope of chemical research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 91061-51-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,0,6 and 1 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 91061-51:
(7*9)+(6*1)+(5*0)+(4*6)+(3*1)+(2*5)+(1*1)=107
107 % 10 = 7
So 91061-51-7 is a valid CAS Registry Number.
91061-51-7Relevant articles and documents
The Synthesis of Chiral α-Aryl α-Hydroxy Carboxylic Acids via RuPHOX-Ru Catalyzed Asymmetric Hydrogenation
Guo, Huan,Li, Jing,Liu, Delong,Zhang, Wanbin
, p. 3665 - 3673 (2017/09/11)
A ruthenocenyl phosphino-oxazoline-ruthenium complex (RuPHOX?Ru) catalyzed asymmetric hydrogenation of α-aryl keto acids has been successfully developed, affording the corresponding chiral α-aryl α-hydroxy carboxylic acids in high yields and with up to 97% ee. The reaction could be performed on a gram scale with a relatively low catalyst loading (up to 5000 S/C) and the resulting products can be transformed to several chiral building blocks, biologically active compounds and chiral drugs. (Figure presented.).
